A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab

Psoriasis is a chronic and debilitating inflammatory immune-mediated skin disorder. Several cytokines including interleukin (IL)-23 were demonstrated to play a central role in the pathogenesis of this disease. Treatment options for psoriasis range from topical to systemic modalities, depending on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazawi, Feras M., Mahmood, Farhan, Kircik, Leon, Poulin, Yves, Bourcier, Marc, Vender, Ronald, Wiseman, Marni C., Lynde, Charles, Litvinov, Ivan V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383205/
https://www.ncbi.nlm.nih.gov/pubmed/34447766
http://dx.doi.org/10.3389/fmed.2021.702776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383205/
https://www.ncbi.nlm.nih.gov/pubmed/34447766
http://dx.doi.org/10.3389/fmed.2021.702776

Ejemplares similares